Basic Immunology
Oxford has fantastic strength in basic immunology research.
Oxford has a wonderful history in immunology research, including determining the structure of antibodies and uncovering the function of lymphocytes. The foundation for understanding human immune disorders and infection is built on the knowledge gained from basic research.
DEPARTMENTS IN THIS THEME
- Nuffield Department of Clinical Medicine
- Department of Zoology
- Radcliffe Department of Medicine
- Sir William Dunn School of Pathology
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
- Nuffield Department of Surgical Sciences
- Department of Biochemistry
- Department of Physiology, Anatomy and Genetics
Recent publications
Click here to view recent publications from this themeWhat's new
Arthritis origins may begin before birth, study finds
12 August 2026
Researchers at the Kennedy Institute have discovered that some joints may be more susceptible to inflammatory arthritis before birth, offering new insight into why rheumatoid arthritis attacks particular joints while sparing others.
Oxford researchers awarded ARIA funding to develop transformative anti-viral therapies
25 June 2026
Three innovative research projects aimed at transforming how we protect against respiratory viruses, led by teams at the University of Oxford, have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).
Natural compound may help boost vaccine responses in older adults
23 June 2026
Researchers from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have found that a naturally occurring compound called spermidine may help improve vaccine responses in some older adults by reducing signs of immune system ageing.
Researchers uncover hidden mechanism behind a major cancer therapy target
9 June 2026
Kennedy researchers have revealed how one of the immune system's most important regulatory pathways operates at the earliest moments of T cell activation, providing new insights that could help improve cancer immunotherapy.








